AXIM insider filings
AXIM BIOTECHNOLOGIES, INC. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-10-15. Screen AXIM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AXIM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — AXIM BIOTECHNOLOGIES, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-10-15 | 4 | Valencia Catalina — President and Director, Director, 10% owner | Purchase (P): 1,086,216 | EDGAR |
| 2024-03-19 | 4 | Valencia Catalina — 10% owner | Grant/award (A): 7,837,500 (derivative) @ $156,750 | EDGAR |
| 2024-03-19 | 4 | Schroeder Blake — Director | Grant/award (A): 35,000 (derivative) @ $35,000 | EDGAR |
| 2024-03-19 | 4 | Cunningham Robert L — Director | Grant/award (A): 35,000 (derivative) @ $35,000 | EDGAR |
| 2024-03-19 | 4 | Scott Timothy Richard — Director | Grant/award (A): 35,000 (derivative) @ $35,000 | EDGAR |
| 2024-03-19 | 4 | O'Rourke Peter — Director | Grant/award (A): 35,000 (derivative) @ $35,000 | EDGAR |
| 2024-03-19 | 4 | HUEMOELLER JOHN WALTER II — Chief Executive Officer, Director | Grant/award (A): 1 (derivative) @ $250,000 | EDGAR |
| 2024-03-19 | 4/A | HUEMOELLER JOHN WALTER II — Chief Executive Officer, Director | Grant/award (A): 250,000 (derivative) @ $250,000 · Grant/award (A): 250,000 (derivative) @ $250,000 | EDGAR |
| 2024-03-19 | 4 | MALASEK ROBERT — Chief Financial Officer | Grant/award (A): 53,500 (derivative) @ $53,500 | EDGAR |
| 2022-09-23 | 4 | Scott Timothy Richard — Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | Schroeder Blake — Director | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | MALASEK ROBERT — Chief Financial Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | Cunningham Robert L — Director | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | Cunningham Robert L — Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | Scott Timothy Richard — Director | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | HUEMOELLER JOHN WALTER II — Chief Executive Officer, Director | Grant/award (A): 5,000,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | HUEMOELLER JOHN WALTER II — Chief Executive Officer, Director | Disposition to issuer (D): 2,000,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | HUEMOELLER JOHN WALTER II — Chief Executive Officer, Director | Grant/award (A): 3,000,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | HUEMOELLER JOHN WALTER II — Chief Executive Officer, Director | Purchase (P): 6,000,000 | EDGAR |
| 2022-09-23 | 4 | HUEMOELLER JOHN WALTER II — Chief Executive Officer, Director | Grant/award (A): 2,000,000 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | MALASEK ROBERT — Chief Financial Officer | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2022-08-31 | 4 | Valencia Catalina — 10% owner | Purchase (P): 3,861,004 @ $0.03 | EDGAR |
| 2022-08-26 | 4 | Schroeder Blake — Director | Conversion (C): 854,012 @ $0.03 | EDGAR |
| 2022-02-15 | 4 | Schroeder Blake — Director | Other (J): 25,000 (derivative) @ $25,000 | EDGAR |
Recent 8-K events — AXIM BIOTECHNOLOGIES, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-10-15 | 8-K | 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-03-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2023-12-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AXIM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs